Hormone Therapy

According to published results, recombinant human growth hormone therapy was associated with increased risk for proximal tibial physeal avulsion fractures in pediatric patients.

Statin therapy could lower the odds of blood clot formation conferred by hormone therapy in perimenopausal women, according to a case-control study published in JAMA Network Open.

A chart review of transgender and nonbinary adolescent patients demonstrated that they are capable of asserting gender-specific care goals in discussions with physicians, a study published in Pediatrics found.

A once-weekly human growth hormone therapy conferred a greater reduction in trunk fat mass and a greater increase in total body lean mass than placebo, according to topline results from a phase 3 trial.

For women experiencing disruptive, bothersome hot flashes, the use of menopausal hormone therapy — a one-time standard but later feared treatment option — is far from straightforward.

The prevalence of transgender-related diagnosis codes in the United States increased nearly ninefold from 2014 to 2021, with significant increases in HIV testing and pre-exposure prophylaxis prescriptions in this population, data show.

Researchers in Peru tested the efficacy of an oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids in alleviating menopause symptoms.

Hormone therapy with transdermal estradiol may benefit bone and CV health and overall quality of life up to 20 years after hysterectomy, according to study results published in Menopause.

Fewer than 1% of adults receiving exogenous testosterone for gender-confirming hormone therapy have a hematocrit level above the norm of 54%, according to data published in The Journal of Clinical Endocrinology & Metabolism.

An oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids was associated with some improved menopausal symptoms short term compared with estrogen plus progestogen therapy, researchers reported in Menopause.